Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Adams

Showing results (61-70 of 163) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Biology|July 1, 1991
Relative change in blood volume following administration of hydralazine as monitored by 19F NMR spectroscopyC Thomas, C J Counsell, P Wood, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Chemosensitization in vitro: potentiation of melphalan toxicity by misonidazole, metronidazole and nitrofurazoneE Smith, C E Lumley, I J Stratford, et al.
Cancer Clinical Trials|January 1, 1980
Respiratory effects and ascorbate reactions with misonidazole and other recently developed drugsB Jacobson, J E Biaglow, E M Fielden, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazolesD J Chaplin, P W Sheldon, I Ahmed, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|July 1, 1974
Selective free radical reactions with proteins and enzymes: the inactivation of alpha-chymotrypsinK Baverstock, R B Cundall, G E Adams, et al.
British Journal of Cancer|May 1, 1990
Bioreductive drugs and the selective induction of tumour hypoxiaJ C Bremner, I J Stratford, J Bowler, et al.
Lancet (London, England)|January 24, 1976
Hypoxic cell sensitisers in radiotherapyG E Adams, S Dische, J F Fowler, et al.
British Journal of Cancer|May 1, 1984
Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivoG E Adams, I Ahmed, P W Sheldon, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivoG E Adams, I Ahmed, P W Sheldon, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|April 1, 1988
Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069J Walling, I J Stratford, G E Adams, et al.
Pageof 17

Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Biology|July 1, 1991
Relative change in blood volume following administration of hydralazine as monitored by 19F NMR spectroscopyC Thomas, C J Counsell, P Wood, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Chemosensitization in vitro: potentiation of melphalan toxicity by misonidazole, metronidazole and nitrofurazoneE Smith, C E Lumley, I J Stratford, et al.
Cancer Clinical Trials|January 1, 1980
Respiratory effects and ascorbate reactions with misonidazole and other recently developed drugsB Jacobson, J E Biaglow, E M Fielden, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazolesD J Chaplin, P W Sheldon, I Ahmed, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|July 1, 1974
Selective free radical reactions with proteins and enzymes: the inactivation of alpha-chymotrypsinK Baverstock, R B Cundall, G E Adams, et al.
British Journal of Cancer|May 1, 1990
Bioreductive drugs and the selective induction of tumour hypoxiaJ C Bremner, I J Stratford, J Bowler, et al.
Lancet (London, England)|January 24, 1976
Hypoxic cell sensitisers in radiotherapyG E Adams, S Dische, J F Fowler, et al.
British Journal of Cancer|May 1, 1984
Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivoG E Adams, I Ahmed, P W Sheldon, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivoG E Adams, I Ahmed, P W Sheldon, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|April 1, 1988
Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069J Walling, I J Stratford, G E Adams, et al.
Pageof 17